BRAFV600E Mutation and Papillary Thyroid Cancer: Chicken or Egg?

被引:20
|
作者
Xing, Mingzhao [1 ]
机构
[1] Johns Hopkins Univ, Div Endocrinol & Metab, Sch Med, Lab Cellular & Mol Thyroid Res, Baltimore, MD 21287 USA
来源
关键词
BRAF MUTATIONS; RET/PTC REARRANGEMENTS; HIGH PREVALENCE; CLINICAL-IMPLICATIONS; KINASE INHIBITORS; CARCINOMA; MELANOMA; HETEROGENEITY; CELLS; VEMURAFENIB;
D O I
10.1210/jc.2012-2201
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2295 / 2298
页数:4
相关论文
共 50 条
  • [41] BRAFV600E Mutation Does Not Mean Distant Metastasis in Thyroid Papillary Carcinomas
    Sancisi, Valentina
    Nicoli, Davide
    Ragazzi, Moira
    Piana, Simonetta
    Ciarrocchi, Alessia
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (09): : E1745 - E1749
  • [42] The relationship between the BRAFV600E mutation in papillary thyroid microcarcinoma and clinicopathologic factors
    Choi, Sun Yi
    Park, HeonSoo
    Kang, Myung Koo
    Lee, Dong Kun
    Lee, Kang Dae
    Lee, Hyoung Shin
    Kim, Sung Won
    Lee, Eun Nam
    Hong, Jong Chul
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11
  • [43] The relationship between the BRAFV600E mutation in papillary thyroid microcarcinoma and clinicopathologic factors
    Sun Yi Choi
    HeonSoo Park
    Myung Koo Kang
    Dong Kun Lee
    Kang Dae Lee
    Hyoung Shin Lee
    Sung Won Kim
    Eun Nam Lee
    Jong Chul Hong
    [J]. World Journal of Surgical Oncology, 11
  • [44] Retrospective study of BRAFV600E mutation and CT features of papillary thyroid carcinoma
    Hong, Xiaoquan
    Li, Juxiang
    Duan, Shaoyin
    You, Youkuang
    [J]. PEERJ, 2024, 12
  • [45] The status of BRAFV600E mutation among Egyptian patients with papillary thyroid carcinoma
    El Tawil A.
    Mehaney D.
    Anis S.
    Salama A.
    Khattab H.
    El-Refaei S.
    [J]. Comparative Clinical Pathology, 2015, 24 (4) : 715 - 720
  • [46] Diversity of oncogenic BRAFV600E pathways in differentiated papillary thyroid cancer
    Shong, Minho
    Lee, Min Hee
    Lee, Seong Jin
    Jo, Young Suk
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S236 - S236
  • [47] The BRAFV600E mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?
    Walczyk, Agnieszka
    Kowalska, Aldona
    Kowalik, Artur
    Sygut, Jacek
    Wypiorkiewicz, Elzbieta
    Chodurska, Renata
    Pieciak, Liliana
    Gozdz, Stanislaw
    [J]. CLINICAL ENDOCRINOLOGY, 2014, 80 (06) : 899 - 904
  • [48] Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status
    Karakose, Melia
    Caliskan, Mustafa
    Arslan, Muyesser Sayki
    Cakal, Erman
    Yesilyurt, Ahmet
    Delibasi, Tuncay
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2015, 59 (04): : 364 - 366
  • [49] BRAFV600E mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness
    Kurtulmus, Neslihan
    Duren, Mete
    Ince, Umit
    Yakicier, M. Cengiz
    Peker, Onder
    Aydin, Ozlem
    Altiok, Ender
    Giray, Serdar
    Azizlerli, Halil
    [J]. ENDOCRINE, 2012, 42 (02) : 404 - 410
  • [50] Combined effect of Hashimoto's thyroiditis and BRAFV600E mutation status on aggressiveness in papillary thyroid cancer
    Kim, Su-jin
    Myong, Jun Pyo
    Jee, Hyeon-Gun
    Chai, Young Jun
    Choi, June Young
    Min, Hye Sook
    Lee, Kyu Eun
    Youn, Yeo-Kyu
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (01): : 95 - 101